Comparison Chart PharmaEssentia Corporation Deutsche Boerse AG
Stocks
8Z1
US7169722037
Biotechnology & Medical Research
|
Market Closed -
Deutsche Boerse AG
10:34:57 09/03/2026 +03
|
5-day change | 1st Jan Change | ||
| 15.50 EUR | -.--% |
|
+11.00% | - |
| 08-31 | PharmaEssentia Gets US FDA's Approval for Essential Thrombocythemia Treament Drug; Shares Sink 10% | MT |
| 08-29 | US FDA approves Takeda, Protagonist's drug for rare blood cancer | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PHARMAESSENTIA CORPORATION | Bio Therapeutic Drugs | -.--% | +11.00% | - | - | - | 17.03B |
-
|
-
|
-
|
- Stock Market
- Stocks
- 6446 Stock
- 8Z1 Stock
- Charts PharmaEssentia Corporation
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
